For instance, biotech giants Vertex Pharmaceuticals (NASDAQ: VRTX) and Incyte (NASDAQ: INCY) -- both of which feature in Wood's Ark Genomic Revolution ETF -- have outperformed the market over the past year. Let's consider why both of these Cathie Wood stocks can still deliver solid returns. It'd be hard to find a biotech giant that has performed better than Vertex Pharmaceuticals this year.